The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
8360878 |
29 |
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
8360871 |
86 |
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-car |
Warner-Lambert |
8515425 |
65 |
Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids. |
Smithkline Beecham Pharmaceuticals |
1875338 |
7 |
Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties. |
Searle R & D and Mcr |
1875348 |
65 |
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. |
E. I. Du Pont De Nemours |
1956044 |
115 |
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. |
Warner-Lambert |
2329554 |
20 |
Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. |
E. I. Du Pont De Nemours And |
2329553 |
81 |
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. |
E. I. Du Pont De Nemours |
2704034 |
16 |
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8. |
Washington State University |
27004954 |
8 |
Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs. |
Donghua University |
25699147 |
6 |
Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands. |
Uppsala University |
20073471 |
15 |
Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome. |
The University of Mississippi |
18318468 |
39 |
Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems. |
Universit£ |
8410980 |
8 |
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists. |
Abbott Laboratories |
| 54 |
4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptor |
TBA |
| 42 |
Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas |
TBA |
| 60 |
The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptors |
TBA |
| 19 |
2,3,6-Substituted quinazolinones as angiotensin II receptor antagonists |
TBA |
| 56 |
Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes |
TBA |
| 134 |
Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes. |
TBA |
| 46 |
Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinities |
TBA |
| 10 |
Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers. |
TBA |
| 34 |
6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonists |
TBA |
18599297 |
50 |
Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships. |
Uppsala University |
17825570 |
32 |
Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system. |
Uppsala University |
12643919 |
50 |
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
10579820 |
4 |
Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor. |
Laboratoires Fournier |
32030982 |
14 |
The Other Angiotensin II Receptor: AT |
Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil |
8515427 |
43 |
Multiple binding modes for the receptor-bound conformations of cyclic AII agonists. |
Washington University |
8258820 |
47 |
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site. |
Dupont Pharmaceuticals |
12593652 |
50 |
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification. |
University of Innsbruck |
10052967 |
2 |
Bicyclic tripeptide mimetics with reverse turn inducing properties. |
Uppsala University |
10579816 |
10 |
Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics. |
Uppsala University |
9784100 |
5 |
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group. |
Wyeth-Ayerst Research |
9083479 |
15 |
Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5. |
Uppsala University |
7473594 |
11 |
4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists. |
Burroughs Wellcome |
7636853 |
35 |
4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization. |
Laboratori Guidotti |
7608902 |
53 |
Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720). |
Hoechst Roussel Pgu Cardiovascular Agents |
8120871 |
19 |
Pyrido[2,3-d]pyrimidine angiotensin II antagonists. |
Wyeth-Ayerst Research |
7966154 |
15 |
Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles. |
Istituto Lusofarmaco |
7932534 |
29 |
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability. |
Glaxo Research and Development |
2362273 |
16 |
Conformational restriction of angiotensin II: cyclic analogues having high potency. |
G.D. Searle And |
1433195 |
55 |
Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model. |
Smithkline Beecham Pharmaceuticals |
25665518 |
18 |
2,3-Dihydroquinazolin-4(1H)-one derivatives as potential non-peptidyl inhibitors of cathepsins B and H. |
Kurukshetra University |